EUVIMEDEUVIMED entdecken
CrossrefInfokarte

From Clinical to Basic Research: The Neuroprotective Effects and Mechanisms of Caffeine

Lijing Wang, Linxi Wang

Health and Metabolism · 2025

DOI: 10.53941/hm.2025.100008 ↗
AbstractBibliografische Angaben

Abstract

Caffeine is the most widely used psychoactive substance in the world, is present in various beverages such as coffee, tea, and energy drinks. Its basic chemical structure contains methylxanthine active components. As a non-selective central adenosine receptor antagonist, caffeine exerts a broad range of pharmacological effects, including antioxidant, anti-inflammatory, and neuroprotective functions. Epidemiological studies and clinical reports suggest that caffeine consumption is closely associated with a reduced risk of neurodegenerative diseases including Alzheimer’s disease, Parkinson’s disease, and dementia. Additionally, caffeine has shown potential benefits in regulating cognitive function, improving depressive symptoms, and reducing the risk of stroke. Although the neuroprotective mechanisms of caffeine remain unclear, current research has revealed that it exerts its effects through multiple signaling pathways, including the inhibition of adenosine A2A receptors, the suppression of neuroinflammation, and the modulation of synaptic plasticity. This paper discusses the recent advancements in research on the neuroprotective effects of caffeine and explores its potential mechanisms and applications in Alzheimer’s disease, Parkinson’s disease, stroke, and depression.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →